Tag: revascularisation
Cerenovus announces European launch of Cereglide 71 aspiration catheter for acute...
Cerenovus, part of Johnson & Johnson MedTech, has today announced the launch of its Cereglide 71 aspiration catheter in Europe, an aspiration catheter equipped...
Black patients nearly 50% less likely to receive revascularisation for PAD
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
Endarterectomy and TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
Female sex “should be considered an independent risk factor” for new...
A preliminary report lends evidence to support female sex being considered as an independent risk factor for new stroke occurrence after carotid revascularisation in...
Carotid stenosis in women: Should the approach differ?
The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...
Study highlights need to extend scope of cerebrovascular health disparities research
A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) ‘All of Us’ research programme dataset of diverse...
Sensome begins first-in-human trial of AI-powered stroke guidewire
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...
Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients.
Best...
First US ischaemic stroke patients treated with Rapid Medical’s novel clot...
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...
Medtronic gets US FDA clearance for Riptide aspiration system
The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...
Neuravi announces European launch of EmboTrap II stent retriever for treatment...
Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will...
Randomised trial of Penumbra 3D revascularisation device meets primary endpoints
The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...
